MedTrace Logo

A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics

NCT00857857 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2018-02-20

Study results available
· View outcomes & findings →

Summary

The study will measure the early and late asthamtic response using an allergen challenge. This study will evaluate the safety and patients tolerance to repeat inhaled doses of GW870086X using a number of clinical and biological markers.

Conditions

Interventions

DRUG

GW870086X

Investigational product

DRUG

FP

Positive control

DRUG

Placebo

Placebo control

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-16
Primary Completion
2009-11-03
Completion
2009-11-03

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00857857 on ClinicalTrials.gov